News for Healthier Living

Blood Biomarker Points to Increased Risk of Brain Metastasis in Patients with Inflammatory Breast Cancer

* Brain metastases are a common complication of inflammatory breast cancer * High levels of soluble E-cadherin in the blood are associated with increased brain metastasis in these patients * A CXCR2 inhibitor reduced metastasis and improved survival in preclinical models, suggesting that targeting this pathway could prevent or treat brain metastasis

January 28, 2026


February 10 2026

February 9 2026

February 8 2026

February 7 2026

February 6 2026

February 5 2026

February 4 2026

February 3 2026

February 2 2026

February 1 2026

January 31 2026

January 30 2026

January 29 2026

January 28 2026

January 27 2026